Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct;41(10):1707-1716.
doi: 10.1007/s00296-021-04832-4. Epub 2021 Mar 18.

The Beighton Score as a measure of generalised joint hypermobility

Affiliations
Review

The Beighton Score as a measure of generalised joint hypermobility

Sabeeha Malek et al. Rheumatol Int. 2021 Oct.

Abstract

The Beighton Score (BS) is a set of manoeuvres in a nine-point scoring system, used as the standard method of assessment for Generalised Joint Hypermobility (GJH). It was originally developed as an epidemiological tool used in screening large populations for GJH, but later adopted as a clinical tool for diagnostic purposes. Its ability to truly reflect GJH remains controversial, as joints within the scoring system are predominantly of the upper limb and disregard many of the major joints, preventing a direct identification of GJH. Furthermore, a consistent finding in the literature whereby the BS failed to identify hypermobility in joints outside the scoring system suggests its use as an indirect indicator of GJH is also not viable. As such, the collective findings of this review demonstrate a need for a change in clinical thinking. The BS should not be used as the principle tool to differentiate between localised and generalised hypermobility, nor used alone to exclude the presence of GJH. Greater emphasis should be placed on a clinician's judgement to identify or exclude GJH, according to its full definition.

Keywords: Beighton score; Ehlers–Danlos Syndrome; Generalised joint hypermobility; Joint hypermobility; Joint hypermobility syndrome; Range of motion; articular.

PubMed Disclaimer

Conflict of interest statement

SM, ER, and GP declare that they have no conflicts of interest.

Similar articles

Cited by

References

    1. Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet. 2017;175(1):148–157. doi: 10.1002/ajmg.c.31539. - DOI - PubMed
    1. Grahame R. Joint hypermobility and genetic collagen disorders: are they related? Arch Dis Child. 1999;80(2):188–191. doi: 10.1136/adc.80.2.188. - DOI - PMC - PubMed
    1. Demmler JC, Atkinson MD, Reinhold EJ, Choy E, Lyons RA, Brophy ST. Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case–control comparison. BMJ Open. 2019;9(11):e031365. doi: 10.1136/bmjopen-2019-031365. - DOI - PMC - PubMed
    1. Carter C, Wilkinson J. Persistent joint laxity and congenital dislocation of the hip. J Bone Joint Surg Br. 1964;46:40–45. doi: 10.1302/0301-620X.46B1.40. - DOI - PubMed
    1. Beighton P, Solomon L, Soskolne CL. Articular mobility in an African population. Ann Rheum Dis. 1973;32(5):413–418. doi: 10.1136/ard.32.5.413. - DOI - PMC - PubMed

LinkOut - more resources